Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experimental research with a new percutaneously insertable and expandable vascular prosthesis].

E P Strecker1, G Berg, H Weber

  • 1Abteilung für Strahlendiagnostik und Nuklearmedizin, Diakonissenkrankenhaus Karlsruhe-Rüppurr, Universität Karlsruhe.

Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|December 1, 1987
PubMed
Summary

A novel arterial endoprosthesis prevents artery re-narrowing (restenosis) and blockage (occlusion) after balloon angioplasty. This device, tested in dogs, demonstrated a nine-month patency rate, offering improved long-term benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.

ESMO open·2021
Same author

3-Dimensional JEG-3 choriocarcinoma cell organoids as a model for trophoblast expansion and differentiation.

Placenta·2021
Same author

Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2016
Same author

A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas.

European journal of cancer (Oxford, England : 1990)·2016
Same author

[Hippocampal stroke].

Der Nervenarzt·2015
Same author

Malfunction of endothelial progenitor cells and endothelial function in patients with Fabry disease.

Journal of stem cells & regenerative medicine·2014

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Materials Science

Context:

  • Transluminal balloon angioplasty is frequently limited by restenosis and occlusion.
  • Existing treatments for post-angioplasty complications have limitations.
  • A need exists for improved methods to maintain arterial patency after intervention.

Purpose:

  • To introduce a novel arterial endoprosthesis designed to prevent restenosis and occlusion following balloon angioplasty.
  • To evaluate the efficacy and feasibility of this new endoprosthesis in a preclinical model.

Summary:

  • A pliable, elastic stainless steel tube endoprosthesis was developed for angioplasty catheters.
  • The endoprosthesis dilates with balloon inflation, providing mechanical support to the arterial wall.

Related Experiment Videos

  • The device was successfully implanted in 12 experimental dogs across various artery sizes, achieving a maximum patency of nine months.

    • Impact:

    • This endoprosthesis shows promise in overcoming the long-term limitations of balloon angioplasty.
    • Potential for improved patient outcomes by reducing the need for re-intervention.
    • Highlights the role of innovative device design in cardiovascular therapy.